J&J Q2 Results: Pharma major beats Wall Street estimates on strong drug sales - The Economic Times
Johnson & Johnson beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and blockbuster ...
The Economic Times
3 hours ago